Bellicum Pharmaceuticals logo
Bellicum Pharmaceuticals BLCM
$ 0.62 -9.72%

Quarterly report 2023-Q3
added 11-14-2023

report update icon

Bellicum Pharmaceuticals Financial Ratios 2011-2025 | BLCM

Annual Financial Ratios Bellicum Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.3 -2.0 -3046.9 -0.6 -1.3 -2.8 -4.6 -6.1 -7.4 - - -

P/S

5.5 3.2 47055.9 8.7 111.4 1405.7 824.5 1055.7 348.2 - - -

EPS

-0.8 -0.8 -1.3 -24.0 -2.4 -2.9 -2.6 -1.8 -34.0 -5.0 - -

EV (Enterprise Value)

-9.74 M -19.9 M 13.1 M 114 M 134 M 272 M 322 M 236 M 433 M 43.1 M 24.7 M -

EBITDA per Share

-0.87 -2.15 0.000763 -16.8 -22.1 -26.4 -24.5 -18.2 -5.56 - - -

EV/EBITDA

1.1 -2884.3 -0.1 -1.3 -3.1 -4.6 -4.7 -30.7 - - -

PEG

0.0 0.0 -30.47 -0.35 -0.08 0.23 0.12 -0.13 0.05 - - -

P/B

0.4 0.5 -9.4 -2.4 1.8 3.1 3.3 2.0 3.2 - - -

P/CF

-0.3 -0.8 -0.4 -0.8 -1.6 -3.1 -5.5 -7.2 -10.7 - - -

ROE %

-1239.35 -39.78 0.31 429.02 -143.16 -108.42 -71.70 -31.94 -43.81 - - -

ROA %

-104.83 -19.75 -0.02 -96.75 -80.69 -67.72 -52.44 -30.27 -42.88 - - -

ROCE %

-1339.01 -101.93 0.02 -400.16 -90.32 -70.83 -58.48 -32.12 -7.61 - - -

Current Ratio

6.3 7.3 1.6 1.2 6.0 8.4 7.0 13.0 53.1 - - -

DSO

- 6.1 1460.0 15.5 296.2 631.4 314.2 569.5 61.1 - - -

DIO

- - - - - - - - - - - -

DPO

- - - - - - - - - - - -

Operating Cycle

- 6.1 - - - - - - - - - -

Cash Conversion Cycle

- 6.1 - - - - - - - - - -
P/E
P/S
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
20222022202120212020202020192019201820182017201720162016201520152014201420132013201220122011201150000 50000 40000 40000 30000 30000 20000 20000 10000 10000 0 0 -10000 -10000
Download SVG
Download PNG
Download CSV

All numbers in USD currency

Quarterly Financial Ratios Bellicum Pharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.02 -0.24 -0.26 - -0.23 -0.13 -0.25 - 0.08 -0.22 -1.12 - -0.18 -8.55 1.09 -5.82 -6.79 -5.85 -5.54 -6.27 -0.55 -0.6 -0.68 -0.66 -0.71 -0.74 -0.8 -0.74 -0.66 -0.61 -0.56 -0.63 -0.51 -0.4 -0.3 -18.99 -2.08 -1.81 -1.52 - - - - - - - - - - - -

EBITDA per Share

- - -0.28 - -0.23 -0.21 -0.19 - -0.29 -0.76 -0.89 - -2.19 -2.14 -2.79 -2.78 -3.8 -4.87 -4.99 -6.1 -0.42 -0.5 -0.62 -0.58 -0.61 -0.67 -0.76 -0.72 -0.59 -0.57 -0.55 -0.63 -0.49 -0.39 -0.29 -1.87 -1.14 -1.39 -1.14 - - - - - - - - - - - -

ROE %

20.80 -78.21 -140.38 -168.08 -178.21 -92.16 -48.20 92.93 128.45 174.11 1888.49 1061.47 1172.02 1258.67 -368.42 429.02 278.73 121.79 -16.25 -143.16 -129.31 -122.23 -115.82 -108.42 -103.18 -93.84 -82.05 -71.70 -62.14 -52.61 -42.44 -31.94 -59.62 -52.94 -47.72 -43.82 -5.04 -2.91 -1.19 - - - - - - - - - - - -

ROA %

-165.11 -177.03 -103.78 -51.40 -45.89 -17.32 -15.58 -39.44 -41.63 -49.32 -146.56 -65.31 -90.24 -115.61 -32.35 -96.75 -94.23 -86.26 -82.99 -80.69 -74.46 -72.16 -70.30 -67.72 -66.65 -62.78 -57.24 -52.44 -47.84 -42.78 -36.85 -30.27 -57.71 -51.44 -46.55 -42.88 -4.94 -2.85 -1.17 - - - - - - - - - - - -

ROCE %

25.95 -72.46 -151.38 -176.19 -151.18 -30.62 70.63 149.17 641.88 1109.58 1525.79 1549.06 1602.08 1198.76 827.66 333.23 241.42 118.10 -16.09 -139.41 -123.59 -116.49 -110.18 -103.24 -100.47 -91.69 -80.43 -70.81 -61.79 -52.70 -42.90 -32.32 -46.91 -39.46 -34.13 -30.18 -4.41 -2.90 -1.19 - - - - - - - - - - - -

Current Ratio

3.0 2.5 3.7 6.3 5.4 8.1 5.5 7.3 1.4 1.2 1.2 1.6 1.6 1.6 1.6 1.0 1.0 1.0 1.0 2.3 2.3 2.3 2.3 2.7 2.7 2.7 2.7 3.7 3.7 3.7 3.7 19.1 19.1 19.1 19.1 47.1 47.1 47.1 47.1 - - - - - - - - - - - -

DSO

- - 45.6 - 55.2 - - - 13.3 83.4 - - - - - 5.4 268.4 19.9 107.2 265.9 284.1 229.1 364.1 -423.2 231.8 - 233.1 376.3 267.4 301.8 383.9 1180.9 704.4 239.0 127.1 906.4 - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - 1394.1 9759.2 - 2477.5 2295.8 10738.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - 45.6 - 55.2 - - - 13.3 83.4 - - - - - 5.4 268.4 19.9 107.2 265.9 284.1 229.1 364.1 -423.2 231.8 - 233.1 376.3 267.4 301.8 383.9 1180.9 704.4 239.0 127.1 906.4 - - - - - - - - - - - - - - -

Cash Conversion Cycle

- - 45.6 - 55.2 - - - 13.3 83.4 - - - - - 5.4 268.4 -1374.2 -9652.0 265.9 -2193.5 -2066.7 -10374.5 -423.2 231.8 - 233.1 376.3 267.4 301.8 383.9 1180.9 704.4 239.0 127.1 906.4 - - - - - - - - - - - - - - -

All numbers in USD currency